Global Cancer News

Gut bacteria may boost cancer therapy by colonizing tumors

A study in mice suggests that by infiltrating tumors and ramping up the body’s immune response, a type of gut bacteria could be a valuable ally in cancer treatment. The authors of the new study note that certain bacteria have also demonstrated the ability to improve the efficacy of cancer…...

Read more

Ancient Chinese medicine unlocks new possibilities for cancer treatment

Source: YaleNews More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a radical idea: What if he could unlock the therapeutic potential of ancient Chinese medicines for treating cancer? What if he could design botanical drugs that would…...

Read more

Proton therapy as effective as standard radiation with fewer side effects

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania.…...

Read more

A quarter of cancer patients experience avoidable delay to diagnosis

One in four cancer patients experienced a delay to their diagnosis that could have been avoided, according to a new study by Cancer Research UK. It found that nearly 3,400 of 14,300 patients experienced a delay that could have been avoided. Half of these patients waited around two months longer to…...

Read more

So-called ‘junk DNA’ affects inherited cancer risk

A person’s risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as ‘junk DNA’, according to new research published in the British Journal of Cancer. This new study shows that inherited cancer risk is not only affected by mutations in key…...

Read more

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with advanced, newly diagnosed ovarian cancer that’s responded to chemotherapy. Olaparib (Lynparza) tablets will be used to help prolong the effects of initial treatment, as a so-called maintenance therapy. The targeted therapy is already available in…...

Read more

Targeted ovarian cancer drug made available to more people on NHS in England

The National Institute for Health and Care Excellence (NICE) has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. Trial results have shown that olaparib, which stops cancer cells repairing damage to their DNA, can give patients more time before their cancer gets…...

Read more

Blood test can quickly match advanced breast cancer patients to targeted treatments

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatments more quickly in the future, Cancer Research UK scientists have found. As part of the plasmaMATCH clinical trial, funded by Stand Up To Cancer, a joint fundraising campaign from Cancer Research UK and Channel…...

Read more

Our biggest cancer news stories of 2019

2019 was a year jam packed with brilliant progress and new challenges for cancer research. Here are some of the top stories of the year: Re-writing the breast cancer rulebook, A cancer breath test enters trials, three new teams take on some of the biggest challenges in cancer research, tracking cancer evolution with the TRACERx lung study,  See more at: https://scienceblog.cancerresearchuk.org/2019/12/17/cruk-biggest-cancer-news-stories-2019/...

Read more

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and Vaccitech Oncology Limited (VOLT), announced Wednesday that a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine treatment developed by VOLT, a strategic collaboration between Vaccitech Ltd and the Ludwig Institute for Cancer Research, is designed to stimulate the body’s immune system to…...

Read more